Pfizer posts earnings beat, raises 2019 profit forecast

- Pfizer Inc on Tuesday beat Wall Street estimates for quarterly profit and slightly raised its earnings forecast for the year, as the largest U.S. drugmaker reined in costs and recorded higher sales of cancer drug Ibrance and pneumonia vaccine Prevnar.

Ibrance brought in sales of $1.13 billion during the quarter, up 21.4 percent from a year earlier, just ahead of analysts’ estimates of $1.12 billion. Prevnar raked in $1.49 billion, beating the average estimate of $1.39 billion. Pfizer is under pressure as one of its biggest drugs, Lyrica, faces generic competition. The company, therefore, has been investing in cancer treatments and gene therapies, and expects to gain approval for a new heart drug, touted as a potential blockbuster, later this year.

So, Congress will be able to heat their swimming pools for another year . . .

GREED over People Can Just Be So Profitable!!! HAHAHAHAHA Don't Actually CURE Anything - Just Advertise Crazy Igotahavitol Wonder Pills To Cure ANYTHING - While Giving You Horendous Side Effects BrainCandy WAKE UP PEOPLE - TRY HARDER!

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

LIVE: Here comes Snap's Q1 2019 earnings...Snapchat parent company Snap announces its Q1 2019 earnings after markets close on Tuesday.
Source: BusinessInsider - 🏆 729. / 51 Read more »

LIVE: Snap stock jumps after beating expectations on revenueSnapchat parent company Snap announces its Q1 2019 earnings after markets close on Tuesday. oh SNAP
Source: BusinessInsider - 🏆 729. / 51 Read more »

LIVE: Snap beat Wall Street's expectations for Q1 2019, and its stock is soaringSnapchat parent company Snap announced its Q1 2019 earnings after markets closed on Tuesday.
Source: BusinessInsider - 🏆 729. / 51 Read more »